Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, August 27, 2014 9:48:43 AM
bullish
$ORGS recent news/filings
## source: finance.yahoo.com
Mon, 25 Aug 2014 10:00:37 GMT ~ ORGENESIS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic
read full: http://biz.yahoo.com/e/140825/orgs8-k.html
*********************************************************
Thu, 07 Aug 2014 10:01:52 GMT ~ ORGENESIS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic
read full: http://biz.yahoo.com/e/140807/orgs8-k.html
*********************************************************
Tue, 05 Aug 2014 17:42:36 GMT ~ ORGENESIS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities
read full: http://biz.yahoo.com/e/140805/orgs8-k.html
*********************************************************
Mon, 04 Aug 2014 13:00:00 GMT ~ Scott Carmer Named as CEO of Orgenesis North America
[Marketwired] - Orgenesis Inc. , a leader in the emerging fields of cellular therapy and re-generative medicine, today announced the appointment of industry veteran Scott Carmer as CEO of the company's North American ...
read full: http://finance.yahoo.com/news/scott-carmer-named-ceo-orgenesis-130000087.html
*********************************************************
Wed, 16 Jul 2014 17:04:08 GMT ~ ORGENESIS INC. Financials
read full: http://finance.yahoo.com/q/is?s=orgs
*********************************************************
$ORGS charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$ORGS company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ORGS/company-info
Ticker: $ORGS
OTC Market Place: OTCQB
CIK code: 0001460602
Company name: Orgenesis, Inc.
Company website: http://www.orgenesis.com
Incorporated In: NV, USA
Business Description: Orgenesis (ORGS) is a development stage company with a novel therapeutic technology that employs a molecular and cellular approach directed at converting a patient's own liver cells into functional insulin producing cells, as a treatment for diabetes. The Company believes that converting the diabetic patient's own tissue into insulin-producing cells overcomes the problem of donor shortage and removes the risk of transplant rejection. If successful, this could mean the end of diabetes, as we now know it. For more information visit: www.orgenesis.com.Less >>
$ORGS share structure
## source: otcmarkets.com
Market Value: $45,531,395 a/o Aug 26, 2014
Shares Outstanding: 54,791,089 a/o Jul 09, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$ORGS extra dd links
Company name: Orgenesis, Inc.
Company website: http://www.orgenesis.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ORGS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ORGS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ORGS+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/news - http://finance.yahoo.com/q/h?s=ORGS+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ORGS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ORGS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ORGS
DTCC (dtcc.com): http://search2.dtcc.com/?q=Orgenesis%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Orgenesis%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Orgenesis%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.orgenesis.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.orgenesis.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.orgenesis.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ORGS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001460602&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ORGS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ORGS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ORGS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ORGS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ORGS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ORGS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ORGS+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ORGS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ORGS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ORGS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ORGS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ORGS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ORGS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ORGS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ORGS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ORGS
$ORGS DD Notes ~ http://www.ddnotesmaker.com/ORGS
Recent ORGS News
- Orgenesis Provides Year End Business Update • GlobeNewswire Inc. • 04/15/2024 09:07:16 PM
- Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility • GlobeNewswire Inc. • 04/10/2024 04:00:00 PM
- Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference • GlobeNewswire Inc. • 03/18/2024 12:30:00 PM
- Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes • GlobeNewswire Inc. • 03/13/2024 12:30:00 PM
- Orgenesis Inc. Announces $2.3 Million Private Placement • GlobeNewswire Inc. • 03/04/2024 01:30:00 PM
- Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing • GlobeNewswire Inc. • 02/29/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 02:20:12 PM
- Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic • GlobeNewswire Inc. • 01/31/2024 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:05:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:01:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 10:37:40 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 10:36:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 11:02:39 AM
- Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TM • GlobeNewswire Inc. • 11/14/2023 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:15:50 PM
- Orgenesis Provides Business Update for the Third Quarter of 2023 • GlobeNewswire Inc. • 11/13/2023 09:15:50 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/09/2023 12:41:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 02:24:05 PM
- Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering • GlobeNewswire Inc. • 11/08/2023 02:00:10 PM
- Orgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant Funding • GlobeNewswire Inc. • 11/02/2023 12:00:00 PM
- Orgenesis Announces Withdrawal of Proposed Public Offering • GlobeNewswire Inc. • 10/31/2023 01:30:00 AM
- Orgenesis Announces Proposed Underwritten Public Offering • GlobeNewswire Inc. • 10/30/2023 08:07:26 PM
- CGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United States • GlobeNewswire Inc. • 09/21/2023 12:00:00 PM
- Cell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard Bauer, Joins Orgenesis Business, Octomera, to Drive Continued Expansion of POCare Facilities and Service Support • GlobeNewswire Inc. • 09/06/2023 11:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM